Smallpox | Global Biodefense

Menu

Lessons for COVID-19 Pandemic from the Massive Public Health Effort to Eradicate Smallpox

Why Is a U.S. Biotech Making Synthetic Vaccinia Virus?

by Global Biodefense Staff February 21, 2020, 9:02 am
Phase 3 Trial of Modified Vaccinia Ankara as a Smallpox Vaccine

by Global Biodefense Staff November 14, 2019, 8:36 pm
FDA Approves Jynneos to Prevent Smallpox and Monkeypox

by Global Biodefense Staff September 24, 2019, 8:00 pm
Explosion Confirmed at Russian Lab Storing Smallpox, Ebola

by Global Biodefense Staff September 21, 2019, 12:00 pm
US Invests Additional 44 Million in Smallpox Vaccine Manufacturing

by Global Biodefense Staff January 22, 2019, 3:26 am
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox

by Global Biodefense Staff October 4, 2018, 3:30 am
CDC to Award Contract to Emergent for 9 Million Doses of Smallpox Vaccine

by Global Biodefense Staff August 12, 2018, 3:36 pm
Factoring Immunosuppression into Smallpox Outbreak Planning

by Global Biodefense Staff April 22, 2018, 10:19 am
USAMRIID-Bavarian Nordic Smallpox Vaccine Phase 3 Study

by Global Biodefense Staff February 19, 2018, 1:10 am
U.S. Seeks to Develop Late-Stage Smallpox Antivirals

by Global Biodefense Staff February 14, 2018, 1:35 pm
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
BARDA BAA 2018: Pandemic Influenza, Infectious Diseases, CBRN Countermeasures

by Global Biodefense Staff November 16, 2017, 12:49 pm
Bavarian Nordic Highlights Smallpox Orders, Vaccine Development

by Global Biodefense Staff November 10, 2017, 8:40 am
Emergent BioSolutions to Acquire Smallpox Vaccine Business from Sanofi

by Global Biodefense Staff July 18, 2017, 4:22 pm
Smallpox Vaccine Potency Testing

by Global Biodefense Staff May 4, 2017, 3:18 pm

Congratulations. You've reached the end of the internet.

Back to Top

Close